[PHAS] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
26-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 38.39%
YoY- -92.03%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 241 703 653 257 411 0 0 -
PBT -11,391 -9,232 -7,293 -4,868 -7,901 -6,674 -4,403 88.34%
Tax 465 469 317 2,975 -2,012 -1,120 -121 -
NP -11,391 -9,232 -7,293 -4,868 -7,901 -6,674 -4,403 88.34%
Tax Rate - - - - - - - -
Total Cost 11,632 9,935 7,946 5,125 8,312 6,674 4,403 90.99%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -4,726.56 -1,313.23 -1,116.85 -1,894.16 -1,922.38 0.00 0.00 -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -0.40 -0.33 -0.30 -0.26 -0.40 -0.34 -0.36 7.26%
EPS Diluted -0.40 -0.33 -0.30 -0.26 -0.40 -0.34 -0.36 7.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.